Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic D…

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
ascopubs.org

Effect of an Invitation or the Effect of Participation: What Should Randomized Controlled Trials of Cancer Screening Examine?

Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial Earlier detection of cancer offers an opportunity to ...
The New England Journal of Medicine

Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases

Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...
Medscape

Potential Biases in TAVI Trials Highlighted

Randomized controlled trials comparing transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) "show serious methodological imbalances with a common selective ...